This partnership will also facilitate graduate placement and industrial training for UTM graduates. The academic programmes and specialised short courses conducted by UTM will work towards providing the industry with skilled manpower and expertise which will drive growth of the biotechnology sector in Malaysia. One of the short courses ‘cGMP Facility for the Production of Biopharmaceuticals and Bioreactor Operation, Maintenance and Troubleshooting’ was conducted specifically for Bio-XCell staff in order to familiarise them with the needs of clients and the industry.
6 December 2011 Bio-XCell Corporate Office, Menara Atlan,
Kuala Lumpur, Malaysia 21 November 2011 BioMalaysia and Pacific Rim Summit on Industrial
Biotechnology &
Bioenergy Kuala Lumpur Convention Centre,
Malaysia
Glycos Biotechnologies Appoints Toyo Malaysia for Construction of Biochemical Facility at Bio-XCell, to be Operational in 2013
Glycos Biotechnologies, Inc. (GlycosBio), an international biochemical company focused on commercialising renewable, high-value specialty chemicals, announced the appointment of Toyo Engineering & Construction Sdn Bhd (Toyo Malaysia) to provide engineering, procurement, and construction (EPC) services for its industrial biochemical production facility at Bio-XCell, scheduled for completion in the second quarter of 2013.
GlycosBio’s commercial facility is being developed in several phases with a targeted production rate capacity of up to 30,000 metric tons per year by 2014 and with a subsequent scale-up to 90,000 metric tons.
Biochemicals targeted for production at GlycosBio’s plant include isoprene, a key building block molecule used in the synthetic rubber industry.
GlycosBio will initially utilise the facility to validate the ability to produce industrial ethanol from crude glycerine. The company will then further demonstrate its flexible technology platform on a commercial scale using a range of feedstocks including fatty acids. Production of isoprene from low-value renewable feedstock readily available in Malaysia at this facility is also planned for development and commercial scale up.
DATE & VENUE EVENT
TECHNOLOGY MANAGEMENT OFFICE: ENHANCING
This partnership will also facilitate graduate placement and industrial training for UTM graduates. The academic programmes and specialised short courses conducted by UTM will work towards providing the industry with skilled manpower and expertise which will drive growth of the biotechnology sector in Malaysia. One of the short courses ‘cGMP Facility for the Production of Biopharmaceuticals and Bioreactor Operation, Maintenance and Troubleshooting’ was conducted specifically for Bio-XCell staff in order to familiarise them with the needs of clients and the industry.
6 December 2011 Bio-XCell Corporate Office, Menara Atlan,
Kuala Lumpur, Malaysia 21 November 2011 BioMalaysia and Pacific Rim Summit on Industrial
Biotechnology &
Bioenergy Kuala Lumpur Convention Centre,
Malaysia
Glycos Biotechnologies Appoints Toyo Malaysia for Construction of Biochemical Facility at Bio-XCell, to be Operational in 2013
Glycos Biotechnologies, Inc. (GlycosBio), an international biochemical company focused on commercialising renewable, high-value specialty chemicals, announced the appointment of Toyo Engineering & Construction Sdn Bhd (Toyo Malaysia) to provide engineering, procurement, and construction (EPC) services for its industrial biochemical production facility at Bio-XCell, scheduled for completion in the second quarter of 2013.
GlycosBio’s commercial facility is being developed in several phases with a targeted production rate capacity of up to 30,000 metric tons per year by 2014 and with a subsequent scale-up to 90,000 metric tons.
Biochemicals targeted for production at GlycosBio’s plant include isoprene, a key building block molecule used in the synthetic rubber industry.
GlycosBio will initially utilise the facility to validate the ability to produce industrial ethanol from crude glycerine. The company will then further demonstrate its flexible technology platform on a commercial scale using a range of feedstocks including fatty acids. Production of isoprene from low-value renewable feedstock readily available in Malaysia at this facility is also planned for development and commercial scale up.
DATE & VENUE EVENT
TECHNOLOGY MANAGEMENT OFFICE: ENHANCING BIOTECH EXCELLENCE
BiotechCorp Technology Management Sdn Bhd (BTM) incorporated on 16 March 2011, is a wholly owned subsidiary of the Malaysian Biotechnology Corporation Sdn Bhd (BiotechCorp). BTM in the interim functions as a division of BiotechCorp also known as the Technology Management Office (TMO). TMO is tasked to manage, develop and commercialise the technologies acquired by BiotechCorp under the 9th Malaysian Plan Biotechnology Acquisition Programme (BAP).
Focus Areas:
tSupercritical Fluid Extraction and Particle Formation Platform Technology: The Supercritical Fluid Extraction and Particle Formation Platform Technology uses the unique properties of carbon dioxide CO2 which at temperatures and pressures exceeding its critical point will be in a high density state with properties of liquid as well as possess high diffusivity, a characteristic of a gas. This allows for extraction beyond the limitations of traditional extraction methods and the ability to produce standardised extracts of high quality. The technology is housed at the Supercritical Fluid Extraction Centre (SFC) in Universiti Putra Malaysia (UPM) that also offers Soxhlet extraction, fractionation and particle formation (aqueous and organic) in addition to supercritical fluid extraction.
tMarker Assisted Selection Platform Technology: The Marker Assisted Selection (MAS) Platform Technology uses DNA markers to identify, link and select desired traits for breeding. The application of this technology significantly accelerates the breeding process from the usual 5 – 6 years in traditional breeding to about 2 years. MAS is particularly useful for traits that are difficult to measure, exhibit low heritability and / or expressed late in development. The technology is housed at the Centre for Marker Discovery and Validation (CMDV) that offers high-throughput genotyping services such as marker discovery, validation and selection as well as DNA finger printing for varietal / Next Steps for Bio-XCell:
We will focus up the following areas to create a vibrant ecosystem for advancements in industrial and healthcare biotechnology in Malaysia.
tIn the current phase of growth (phase 1) we will continue to focus on building up activities in biomanufacturing and bioprocessing by engaging with regional and global biotech industry players to attract foreign direct investment. Infrastructure and facilities are being developed at Bio-XCell to support the needs of these industry leaders.
tIn gearing up for the next phase (phase II), we will focus on promoting innovation, R&D activities and the bioeconomy. We hope to catalyse the participation of local companies in R&D projects which will fuel future product pipelines. We also hope to develop local capabilities through technology transfer and technology licensing in this phase.
t5IFNJDSPTUSBUFHJFTGPSFBDIQIBTFXJMMCFSFGJOFEBTXFHPBMPOHJOMJOFXJUIHMPCBMBOE regional market trends, in optimising value creation for the local biotechnology sector and the economy.
In achieving these objectives Bio-XCell will be an effective platform for commercialisation in biotechnology, in meeting the objectives of Phase 2 of the National Biotechnology Policy (NBP) – the Science to Business phase.
Furthermore, initiatives by Bio-XCell are gearing up to fulfil Phase 3 of the NBP- Building and Establishing Global Businesses in Biotechnology.
t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t /BOPUFDIOPMPHZ1MBUGPSN5IF/BOPUFDIOPMPHZ1MBUGPSNBMMPXTUIFEFTJHOBOETZOUIFTJTPG
NVMUJGVODUJPOBMJOPSHBOJDOBOPQBSUJDMFTPGTQFDJGJDTJ[FTGPSBXJEFSBOHFPGBQQMJDBUJPOTJO GJFMET TVDI BT NBUFSJBMT IFBMUIDBSF DPTNFDFVUJDBM BHSJDVMUVSF BT XFMM BT JOEVTUSJBM BOE FOWJSPONFOUBM EJBHOPTUJD LJUT 5IF OBOPQBSUJDMFT DBO HFOFSBUF QIZTJDBM PS DIFNJDBM SFBDUJPOTDPOUSPMMFECZBOFYUFSOBMTPVSDFTVDIBT
/BOP.BHo"DUJWBUJPOCZBNBHOFUJDGJFME FH.3*
/BOP1%5o"DUJWBUJPOCZBMJHIUTPVSDF FH-BTFS /BOP93BZo"DUJWBUJPOCZ93BZ
5IF GPMMPXJOH BSF TVCTJEJBSJFT JODPSQPSBUFE VOEFS #JPUFDI$PSQ 5FDIOPMPHZ .BOBHFNFOU 4EO#IE
J #JPUFDI$PSQ4VQFSDSJUJDBM4PMVUJPOT4EO#IE JJ #JPUFDI$PSQ.PMFDVMBS4PMVUJPOT4EO#IE JJJ #JPUFDI$PSQ%JBHOPTUJD4PMVUJPOT4EO#IE JW #JPUFDI$PSQ/BOPUFDI4PMVUJPOT4EO#IE
4VQFSDSJUJDBM'MVJE
&YUSBDUJPOBOE 1BSUJDMF'PSNBUJPO 1MBUGPSN5FDIOPMPHZ
5IF4VQFSDSJUJDBM'MVJE&YUSBDUJPO$FOUSF 4'$IBTCFFOTVDDFTTGVMMZ TFUVQ BU UIF 'BDVMUZ PG 'PPE 4DJFODF 5FDIOPMPHZ JO 61. BOE JT DVSSFOUMZ VOEFSHPJOH UIF OFDFTTBSZ SFHVMBUPSZ BQQSPWBMT BOE JT FTUJNBUFEUPDPNNFODFJUTPQFSBUJPOTBUUIFFOEPGUIFUIJSERVBSUFSPG
*O5.0QSPNPUFEUIFQMBUGPSNCZ
t 1BSUJDJQBUJOHJOUIF.BMBZTJB4DJFODF5FDIOPMPHZ*OOPWBUJPO NZ45*
&YQPTJUJPO
t $PMMBCPSBUJOH XJUI :BLJO #JPMBCT 4EO #IE UP PSHBOJTF B TFNJOBS PO
“$02 #PUBOJDBM &YUSBDUT BT UIF #FUUFS "MUFSOBUJWF UIBO $POWFOUJPO
Issue/Activity Results
Key Results
t 0SHBOJTJOHBUBMLCZ%S/PSBOJ[BO.PIE"E[BIBOGSPN61.EVSJOHUIF TFNJOBS PO i$02 #PUBOJDBM &YUSBDUT BT UIF #FUUFS "MUFSOBUJWF UIBO
$POWFOUJPO4PMWFOU&YUSBDUTwPO%FDFNCFS t 1BSUJDJQBUJOHJOUIF#JP.BMBZTJB&YIJCJUJPO
t 0SHBOJTJOH B UBML CZ %S $IPOH (VO )FBO PO 4VQFSDSJUJDBM 'MVJE
&YUSBDUJPO 5FDIOPMPHZ BOE 4VQFSDSJUJDBM 'MVJE $FOUSF JO 61. EVSJOH
#JP.BMBZTJB .BSLFS"TTJTUFE
4FMFDUJPO1MBUGPSN 5FDIOPMPHZ
5IF$FOUSFGPS.BSLFS%JTDPWFSZBOE7BMJEBUJPO $.%7IBTCFFOGVMMZ TFUVQBOEDPNNFODFEJUTPQFSBUJPOTJOBGUFSBTVDDFTTGVMMBVODI EVSJOH#JP.BMBZTJBJOUIFQSFTFODFPG1SJNF.JOJTUFSPG.BMBZTJB :"#%BUP4SJ/BKJC5VO3B[BL
%VSJOH UIF MBVODI #JPUFDI$PSQ BOE .BMBZTJBO "HSJDVMUVSBM 3FTFBSDI BOE%FWFMPQNFOU*OTUJUVUF ."3%*IBETJHOFEBHSFFNFOUTXJUI+&'*
"RVBUFDI3FTPVSDFT4EO#IE.BMBZTJBO1BMN0JM#PBSE .10#BOE (SFFO8PSME(FOFUJDT4EO#IEUPVUJMJTFUIFTFSWJDFTPGGFSFECZ$.%7 5.0JODSFBTFEQVCMJDBXBSFOFTTPOUIF."41MBUGPSN5FDIOPMPHZCZ t 0SHBOJTJOH BO *OUSPEVDUPSZ 4FNJOBS PO $FOUSF GPS .BSLFS %JTDPWFSZ
BOE7BMJEBUJPOPO+VOF
t 1BSUJDJQBUJOH JO UIF .BMBZTJBO 4DJFODF 5FDIOPMPHZ *OOPWBUJPO NZ45*&YQPTJUJPO
t 1BSUJDJQBUJOHJOUIF#JP.BMBZTJB&YIJCJUJPO
t 0SHBOJTJOHBUBMLCZ%S6NJ,BMTPNCJOUJ"CV#BLBSGSPN."3%*PO i*OUSPEVDUJPO UP UIF $FOUSF GPS .BSLFS %JTDPWFSZ BOE 7BMJEBUJPO $.%7wEVSJOH#JP.BMBZTJB
%PU4DBO1MBUGPSN 5FDIOPMPHZ
5IFUFDIOPMPHZUSBOTGFSGPSUIF%PU4DBO1MBUGPSN5FDIOPMPHZIBTCFFO TVDDFTTGVM XJUI UXP UFDIOPMPHZ DVTUPEJBOT UIF *OTUJUVUF GPS .FEJDBM 3FTFBSDI *.3BOE61.#PUIPSHBOJTBUJPOTBSFDVSSFOUMZDPOEVDUJOH SFTFBSDI UPXBSET UIF EFWFMPQNFOU PG OFX BQQMJDBUJPOT VUJMJTJOH UIF
%PU4DBO1MBUGPSN5FDIOPMPHZ*OBEEJUJPOUIJT1MBUGPSN5FDIOPMPHZIBT HBSOFSFEJOUFSFTUGSPNTFWFSBMSFTFBSDIFSTBTXFMMBTGSPNUIFJOEVTUSZ LFFOUPEFWFMPQBQQMJDBUJPOTJOMJOFXJUIUIFJSSFTFBSDIJOUFSFTUBTXFMMBT UP DPNNFSDJBMJTF UIF BWBJMBCMF -FVLBFNJB BQQMJDBUJPO VTJOH %PU4DBO 5.0QSPNPUFEUIF%PU4DBO1MBUGPSN5FDIOPMPHZCZ
t 1BSUJDJQBUJOH JO UIF .BMBZTJB 4DJFODF 5FDIOPMPHZ BOE *OOPWBUJPO NZ45*&YQPTJUJPO
Issue/Activity Results
t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t /BOPUFDIOPMPHZ1MBUGPSN5IF/BOPUFDIOPMPHZ1MBUGPSNBMMPXTUIFEFTJHOBOETZOUIFTJTPG
NVMUJGVODUJPOBMJOPSHBOJDOBOPQBSUJDMFTPGTQFDJGJDTJ[FTGPSBXJEFSBOHFPGBQQMJDBUJPOTJO GJFMET TVDI BT NBUFSJBMT IFBMUIDBSF DPTNFDFVUJDBM BHSJDVMUVSF BT XFMM BT JOEVTUSJBM BOE FOWJSPONFOUBM EJBHOPTUJD LJUT 5IF OBOPQBSUJDMFT DBO HFOFSBUF QIZTJDBM PS DIFNJDBM SFBDUJPOTDPOUSPMMFECZBOFYUFSOBMTPVSDFTVDIBT
/BOP.BHo"DUJWBUJPOCZBNBHOFUJDGJFME FH.3*
/BOP1%5o"DUJWBUJPOCZBMJHIUTPVSDF FH-BTFS /BOP93BZo"DUJWBUJPOCZ93BZ
5IF GPMMPXJOH BSF TVCTJEJBSJFT JODPSQPSBUFE VOEFS #JPUFDI$PSQ 5FDIOPMPHZ .BOBHFNFOU 4EO#IE
J #JPUFDI$PSQ4VQFSDSJUJDBM4PMVUJPOT4EO#IE JJ #JPUFDI$PSQ.PMFDVMBS4PMVUJPOT4EO#IE JJJ #JPUFDI$PSQ%JBHOPTUJD4PMVUJPOT4EO#IE JW #JPUFDI$PSQ/BOPUFDI4PMVUJPOT4EO#IE
4VQFSDSJUJDBM'MVJE
&YUSBDUJPOBOE 1BSUJDMF'PSNBUJPO 1MBUGPSN5FDIOPMPHZ
5IF4VQFSDSJUJDBM'MVJE&YUSBDUJPO$FOUSF 4'$IBTCFFOTVDDFTTGVMMZ TFUVQ BU UIF 'BDVMUZ PG 'PPE 4DJFODF 5FDIOPMPHZ JO 61. BOE JT DVSSFOUMZ VOEFSHPJOH UIF OFDFTTBSZ SFHVMBUPSZ BQQSPWBMT BOE JT FTUJNBUFEUPDPNNFODFJUTPQFSBUJPOTBUUIFFOEPGUIFUIJSERVBSUFSPG
*O5.0QSPNPUFEUIFQMBUGPSNCZ
t 1BSUJDJQBUJOHJOUIF.BMBZTJB4DJFODF5FDIOPMPHZ*OOPWBUJPO NZ45*
&YQPTJUJPO
t $PMMBCPSBUJOH XJUI :BLJO #JPMBCT 4EO #IE UP PSHBOJTF B TFNJOBS PO
“$02 #PUBOJDBM &YUSBDUT BT UIF #FUUFS "MUFSOBUJWF UIBO $POWFOUJPO
Issue/Activity Results
Key Results
t 0SHBOJTJOHBUBMLCZ%S/PSBOJ[BO.PIE"E[BIBOGSPN61.EVSJOHUIF TFNJOBS PO i$02 #PUBOJDBM &YUSBDUT BT UIF #FUUFS "MUFSOBUJWF UIBO
$POWFOUJPO4PMWFOU&YUSBDUTwPO%FDFNCFS t 1BSUJDJQBUJOHJOUIF#JP.BMBZTJB&YIJCJUJPO
t 0SHBOJTJOH B UBML CZ %S $IPOH (VO )FBO PO 4VQFSDSJUJDBM 'MVJE
&YUSBDUJPO 5FDIOPMPHZ BOE 4VQFSDSJUJDBM 'MVJE $FOUSF JO 61. EVSJOH
#JP.BMBZTJB .BSLFS"TTJTUFE
4FMFDUJPO1MBUGPSN 5FDIOPMPHZ
5IF$FOUSFGPS.BSLFS%JTDPWFSZBOE7BMJEBUJPO $.%7IBTCFFOGVMMZ TFUVQBOEDPNNFODFEJUTPQFSBUJPOTJOBGUFSBTVDDFTTGVMMBVODI EVSJOH#JP.BMBZTJBJOUIFQSFTFODFPG1SJNF.JOJTUFSPG.BMBZTJB :"#%BUP4SJ/BKJC5VO3B[BL
%VSJOH UIF MBVODI #JPUFDI$PSQ BOE .BMBZTJBO "HSJDVMUVSBM 3FTFBSDI BOE%FWFMPQNFOU*OTUJUVUF ."3%*IBETJHOFEBHSFFNFOUTXJUI+&'*
"RVBUFDI3FTPVSDFT4EO#IE.BMBZTJBO1BMN0JM#PBSE .10#BOE (SFFO8PSME(FOFUJDT4EO#IEUPVUJMJTFUIFTFSWJDFTPGGFSFECZ$.%7 5.0JODSFBTFEQVCMJDBXBSFOFTTPOUIF."41MBUGPSN5FDIOPMPHZCZ t 0SHBOJTJOH BO *OUSPEVDUPSZ 4FNJOBS PO $FOUSF GPS .BSLFS %JTDPWFSZ
BOE7BMJEBUJPOPO+VOF
t 1BSUJDJQBUJOH JO UIF .BMBZTJBO 4DJFODF 5FDIOPMPHZ *OOPWBUJPO NZ45*&YQPTJUJPO
t 1BSUJDJQBUJOHJOUIF#JP.BMBZTJB&YIJCJUJPO
t 0SHBOJTJOHBUBMLCZ%S6NJ,BMTPNCJOUJ"CV#BLBSGSPN."3%*PO i*OUSPEVDUJPO UP UIF $FOUSF GPS .BSLFS %JTDPWFSZ BOE 7BMJEBUJPO $.%7wEVSJOH#JP.BMBZTJB
%PU4DBO1MBUGPSN 5FDIOPMPHZ
5IFUFDIOPMPHZUSBOTGFSGPSUIF%PU4DBO1MBUGPSN5FDIOPMPHZIBTCFFO TVDDFTTGVM XJUI UXP UFDIOPMPHZ DVTUPEJBOT UIF *OTUJUVUF GPS .FEJDBM 3FTFBSDI *.3BOE61.#PUIPSHBOJTBUJPOTBSFDVSSFOUMZDPOEVDUJOH SFTFBSDI UPXBSET UIF EFWFMPQNFOU PG OFX BQQMJDBUJPOT VUJMJTJOH UIF
%PU4DBO1MBUGPSN5FDIOPMPHZ*OBEEJUJPOUIJT1MBUGPSN5FDIOPMPHZIBT HBSOFSFEJOUFSFTUGSPNTFWFSBMSFTFBSDIFSTBTXFMMBTGSPNUIFJOEVTUSZ LFFOUPEFWFMPQBQQMJDBUJPOTJOMJOFXJUIUIFJSSFTFBSDIJOUFSFTUBTXFMMBT UP DPNNFSDJBMJTF UIF BWBJMBCMF -FVLBFNJB BQQMJDBUJPO VTJOH %PU4DBO 5.0QSPNPUFEUIF%PU4DBO1MBUGPSN5FDIOPMPHZCZ
t 1BSUJDJQBUJOH JO UIF .BMBZTJB 4DJFODF 5FDIOPMPHZ BOE *OOPWBUJPO NZ45*&YQPTJUJPO
Issue/Activity Results
Next Steps for Technology Management Office:
The Technology Management Office (TMO) will continue to manage and commercialise platform technologies via the following strategies:
t &OHBHF XJUI JOEVTUSZ QMBZFST BOE DPNNFSDJBM QBSUOFST UP JODSFBTF BXBSFOFTT BOE accelerate the adoption of the technologies as well as increasing the client base for the platform technologies.
t 5PJODSFBTFUIFUFDIOJDBMNBOQPXFSBOEUSBJOJOHPGUIFCBDLVQUFBNTPGFBDIUFDIOPMPHZ to ensure the technology custodians are able to efficiently and effectively provide services to their clientele.
t 5PEFWFMPQDPMMBCPSBUJPOTUPFOTVSFJODSFBTFEVUJMJTBUJPOPGUIFQMBUGPSNUFDIOPMPHJFT t 5P EFWFMPQ BOE DPOUJOVPVTMZ TUBOEBSEJTF UIF CVTJOFTT BOE TUBOEBSE PQFSBUJOH
procedures (SOP) of the technology custodians. Improvement in management and SOPs XPVMEIBTUFOUIFUSBOTGPSNBUJPOPG$.%7BOE4'&UPBDPNNFSDJBMFOUJUZUIBUQSPWJEFT efficient and effective services to their clients.
t 5PBTTJTUUIFUFDIOPMPHZDVTUPEJBOTJONBOBHJOHUIFJSDMJFOUTBTSFRVJSFECFGPSFEVSJOH and after the services are rendered.
t 5PMJBJTFXJUIUIFUFDIOPMPHZMJDFOTPSTUPFOTVSFUIBUSFRVJSFETVQQPSUJTQSPWJEFEUPUIF technology custodians.
TMO will also be expanding its scope of business to offer:
t $VTUPNJTFETFSWJDFTUPPSHBOJTBUJPOTTVDIBTSFTFBSDIJOTUJUVUFTVOJWFSTJUJFTHPWFSONFOU agencies and private companies for the commercialisation of intellectual property.
t #VTJOFTTQMBOXPSLTIPQTGPSDPNQBOJFTBQQMZJOHGPSUIF#JP/FYVT4UBUVT t 0SHBOJTJOHBUBMLCZUIFDPJOWFOUPS1SPGFTTPS3JDIBSE$ISJTUPQIFSTPO
PO i4VSGBDF 1SPGJMJOH PG -FVLBFNJBT -ZNQIPNBT BOE $PMPSFDUBM
$BODFSTVTJOH%PU4DBO"OUJCPEZ.JDSPBSSBZTwEVSJOH#JP.BMBZTJB t 0SHBOJTJOHBUBMLCZ%S"CIJNBOZV7FFSBLVNBSBTJWBNGSPN61.PO
i/PWFM "QQMJDBUJPOT GPS %PU4DBO "OUJCPEZ .JDSPBSSBZTw EVSJOH
#JP.BMBZTJB /BOPUFDIOPMPHZ
Platform
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fluorescence microscopy facility and a biological laboratory. Research CZ /BOP#3* JODMVEFT UIF EFTJHO BOE EFWFMPQNFOU PG OBOPQBSUJDMFT OBOPDPMMPJET SFBHFOU EFTJHO ESVH BOE NPMFDVMF DBSSJFS EFTJHO BOE EFWFMPQNFOUDFMMVMBSJNBHJOHBOEEJBHOPTUJDQMBUGPSNT*UJTDVSSFOUMZ BCMFUPQSPEVDF/BOP4JMJDB/BOP.BHOFUJD/BOP(PMEBOE-JQPTPNF nanoparticles. There is also an online nanotechnology platform for QSFBQQMJDBUJPOGPSUIPTFJOUFSFTUFEJOTVCMJDFOTJOHUIFUFDIOPMPHZ*O BEEJUJPOUPUIBUJOUPQSPNPUFOBOPUFDIOPMPHZBOEDSFBUFNPSF BXBSFOFTT5.0BMTPDBSSJFEPVUUIFGPMMPXJOHBDUJWJUJFT
t 0SHBOJTJOH B UBML EVSJOH UIF )FBMUIDBSF 4FNJOBS GPS #JP/FYVT
$PNQBOJFTPSHBOJTFECZUIF#VTJOFTT%FWFMPQNFOUBOE*OWFTUNFOU
%JWJTJPOo)FBMUIDBSFPO.BSDI
t 1BSUJDJQBUJOH JO UIF .BMBZTJB 4DJFODF 5FDIOPMPHZ BOE *OOPWBUJPO NZ45*&YQPTJUJPO
t 1BSUJDJQBUJOHJOUIF#JP.BMBZTJB&YIJCJUJPO
t 0SHBOJTJOHBUBMLCZ"TTPD1SPG%S"[MBO"CEVM"[J[GSPN64.PO i"QQMJDBUJPO CBTFE PO UIF /BOPUFDIOPMPHZ 1MBUGPSNw EVSJOH
#JP.BMBZTJB
Issue/Activity Results
Next Steps for Technology Management Office:
The Technology Management Office (TMO) will continue to manage and commercialise platform technologies via the following strategies:
t &OHBHF XJUI JOEVTUSZ QMBZFST BOE DPNNFSDJBM QBSUOFST UP JODSFBTF BXBSFOFTT BOE accelerate the adoption of the technologies as well as increasing the client base for the platform technologies.
t 5PJODSFBTFUIFUFDIOJDBMNBOQPXFSBOEUSBJOJOHPGUIFCBDLVQUFBNTPGFBDIUFDIOPMPHZ to ensure the technology custodians are able to efficiently and effectively provide services to their clientele.
t 5PEFWFMPQDPMMBCPSBUJPOTUPFOTVSFJODSFBTFEVUJMJTBUJPOPGUIFQMBUGPSNUFDIOPMPHJFT t 5P EFWFMPQ BOE DPOUJOVPVTMZ TUBOEBSEJTF UIF CVTJOFTT BOE TUBOEBSE PQFSBUJOH
procedures (SOP) of the technology custodians. Improvement in management and SOPs XPVMEIBTUFOUIFUSBOTGPSNBUJPOPG$.%7BOE4'&UPBDPNNFSDJBMFOUJUZUIBUQSPWJEFT efficient and effective services to their clients.
t 5PBTTJTUUIFUFDIOPMPHZDVTUPEJBOTJONBOBHJOHUIFJSDMJFOUTBTSFRVJSFECFGPSFEVSJOH and after the services are rendered.
t 5PMJBJTFXJUIUIFUFDIOPMPHZMJDFOTPSTUPFOTVSFUIBUSFRVJSFETVQQPSUJTQSPWJEFEUPUIF technology custodians.
TMO will also be expanding its scope of business to offer:
t $VTUPNJTFETFSWJDFTUPPSHBOJTBUJPOTTVDIBTSFTFBSDIJOTUJUVUFTVOJWFSTJUJFTHPWFSONFOU agencies and private companies for the commercialisation of intellectual property.
t #VTJOFTTQMBOXPSLTIPQTGPSDPNQBOJFTBQQMZJOHGPSUIF#JP/FYVT4UBUVT t 0SHBOJTJOHBUBMLCZUIFDPJOWFOUPS1SPGFTTPS3JDIBSE$ISJTUPQIFSTPO
PO i4VSGBDF 1SPGJMJOH PG -FVLBFNJBT -ZNQIPNBT BOE $PMPSFDUBM
$BODFSTVTJOH%PU4DBO"OUJCPEZ.JDSPBSSBZTwEVSJOH#JP.BMBZTJB t 0SHBOJTJOHBUBMLCZ%S"CIJNBOZV7FFSBLVNBSBTJWBNGSPN61.PO
i/PWFM "QQMJDBUJPOT GPS %PU4DBO "OUJCPEZ .JDSPBSSBZTw EVSJOH
#JP.BMBZTJB /BOPUFDIOPMPHZ
Platform
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fluorescence microscopy facility and a biological laboratory. Research CZ /BOP#3* JODMVEFT UIF EFTJHO BOE EFWFMPQNFOU PG OBOPQBSUJDMFT OBOPDPMMPJET SFBHFOU EFTJHO ESVH BOE NPMFDVMF DBSSJFS EFTJHO BOE EFWFMPQNFOUDFMMVMBSJNBHJOHBOEEJBHOPTUJDQMBUGPSNT*UJTDVSSFOUMZ BCMFUPQSPEVDF/BOP4JMJDB/BOP.BHOFUJD/BOP(PMEBOE-JQPTPNF nanoparticles. There is also an online nanotechnology platform for QSFBQQMJDBUJPOGPSUIPTFJOUFSFTUFEJOTVCMJDFOTJOHUIFUFDIOPMPHZ*O BEEJUJPOUPUIBUJOUPQSPNPUFOBOPUFDIOPMPHZBOEDSFBUFNPSF BXBSFOFTT5.0BMTPDBSSJFEPVUUIFGPMMPXJOHBDUJWJUJFT
t 0SHBOJTJOH B UBML EVSJOH UIF )FBMUIDBSF 4FNJOBS GPS #JP/FYVT
$PNQBOJFTPSHBOJTFECZUIF#VTJOFTT%FWFMPQNFOUBOE*OWFTUNFOU
%JWJTJPOo)FBMUIDBSFPO.BSDI
t 1BSUJDJQBUJOH JO UIF .BMBZTJB 4DJFODF 5FDIOPMPHZ BOE *OOPWBUJPO NZ45*&YQPTJUJPO
t 1BSUJDJQBUJOHJOUIF#JP.BMBZTJB&YIJCJUJPO
t 0SHBOJTJOHBUBMLCZ"TTPD1SPG%S"[MBO"CEVM"[J[GSPN64.PO i"QQMJDBUJPO CBTFE PO UIF /BOPUFDIOPMPHZ 1MBUGPSNw EVSJOH
#JP.BMBZTJB
Issue/Activity Results